Health Canada Asked Pfizer for DNA Fragments Size ion COVID Shots, Linked to ‘Probability’ of Genomic ‘Integration’
1st May 2024
Canada’s drug regulator asked Pfizer to provide data on the size of DNA fragments in its COVID-19 vaccine, due to genomic integration concerns, shortly after learning the pharma giant withheld information on DNA sequences contained in its product.
“Concerning the residual plasmid DNA in the drug substance, provide data/information characterizing […] the size distribution of the residual DNA fragments [and] residual intact circular plasmid,” says a request for clarification Health Canada issued to Pfizer on Aug. 4, 2023.